Taste Masking용 의약품 부형제 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2024-2033년)

Pharmaceutical Excipients For Taste Masking Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

US $ 4,995 ￦ 7,411,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295 ￦ 10,823,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495 ￦ 12,604,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

한글목차

Persistence Market Research는 최근 세계 Taste Masking용 의약품 부형제 시장에 대한 종합적인 보고서를 발표했습니다. 이 보고서는 촉진요인, 동향, 기회 및 과제와 같은 중요한 시장 역학을 철저히 평가하고 시장 구조에 대한 심층적인 통찰력을 제공합니다.

주요 인사이트

• Taste Masking용 의약품 부형제 시장 규모(2024년) : 9억 8,560만 달러
• 2033년 예상 시장 규모(2033년) : 15억 3,920만 달러
• 세계 시장 성장률(2024-2033년 CAGR) : 5.1%

Taste Masking용 의약품 부형제 시장 : 연구 범위

Taste Masking용 의약품 부형제는 의약품 제형에서 중요한 역할을 하며, 불쾌한 맛과 냄새를 마스킹하여 환자의 순응도를 향상시킵니다. 이러한 첨가제는 정제, 시럽제, 분말제 등 다양한 제형에 걸쳐 사용되어 의약품의 기호성을 향상시킵니다. 이 시장은 제약사, CRO, CMO를 대상으로 향료, 감미료, 코팅재를 포함한 다양한 첨가제를 제공합니다.

시장 성장의 촉진요인:

Taste Masking용 의약품 부형제 세계 시장은 환자의 복약 순응도를 높이기 위해 효과적인 Taste Masking 솔루션이 필요한 소아 및 노인 의약품에 대한 수요 증가와 같은 몇 가지 중요한 요인에 힘입어 성장하고 있습니다. 경구용 의약품에 대한 소비자 선호도 증가와 새로운 Taste Masking제 및 첨단 코팅 소재 개발과 같은 첨가제 기술의 발전은 시장 확대를 더욱 촉진하고 있습니다. 일반의약품(OTC) 분야의 성장과 개인 맞춤형 의료에 대한 관심 증가도 혁신적인 Taste Masking 솔루션에 대한 수요에 기여하고 있습니다.

시장 성장 억제요인 :

유망한 성장 전망에도 불구하고, Taste Masking용 의약품 부형제 시장은 첨단 첨가제 기술의 높은 비용과 규제 장벽과 관련된 문제에 직면해 있습니다. 첨가제의 안전성과 유효성을 규정하는 엄격한 규제는 제조업체에 컴플라이언스 부담을 가중시키고 운영 비용을 증가시킵니다. 또한, 특정 제형에 사용할 수 있는 맛 마스킹 솔루션이 제한되어 있고, 새로운 첨가제를 개발하기 위해 지속적인 R&D 투자가 필요하다는 점도 시장 개척에 어려움을 겪고 있습니다.

시장 기회 :

Taste Masking용 의약품 부형제 시장은 기술 혁신, 인구 동향 및 진화하는 제형에 의해 큰 성장 기회를 맞이하고 있습니다. 나노기술과 고분자 기반 첨가제와 같은 첨단 기술의 통합은 Taste Masking 효과를 향상시켜 시장 성장의 새로운 길을 열어줄 것입니다. 또한, 신흥국 시장의 제약 산업 확대와 환자 중심 의약품 개발에 대한 관심이 높아지면서 시장 참여자들에게 비용 효율적이고 효율적인 Taste Masking 솔루션을 도입할 수 있는 기회로 작용할 수 있습니다. 전략적 파트너십, R&D 투자, 사용자 친화적인 첨가제 채택은 새로운 기회를 활용하고 역동적인 Taste Masking 시장에서 리더십을 유지하는 데 필수적입니다.

본 보고서에서 다룬 주요 질문들

• Taste Masking용 의약품 부형제 시장의 세계 성장을 가속하는 주요 요인은?
• 다양한 제약 제제에서 Taste Masking의 채택을 촉진하는 첨가제의 유형과 용도는?
• 기술 발전은 Taste Masking용 의약품 부형제 시장 경쟁 구도를 어떻게 변화시키고 있는가?
• Taste Masking용 의약품 부형제 시장에 기여하는 주요 기업은?
• 세계 Taste Masking용 의약품 부형제 시장의 새로운 트렌드와 전망은?

목차

제1장 주요 요약

제2장 시장 개요

• 시장 범위/분류
• 시장의 정의/범위/제한
• 포함 사항 및 제외 사항

제3장 주요 시장 동향

• 시장에 영향을 미치는 주요 동향
• 첨가제 혁신/개발 동향

제4장 주요 성공 요인

• 제품 채택/사용 상황 분석
• 제품의 USP/특징
• 최근의 제품 승인과 발매
• 파이프라인 평가
• PESTLE 분석
• Porter의 Five Forces 분석
• 규제 시나리오

제5장 시장 배경

• 거시경제 요인
• 예측 요인 - 관련성과 영향
• 역학

제6장 COVID-19 위기 - 영향 평가

• COVID-19와 영향 분석
  • 첨가제별
  • 기술별
  • 용도별
  • 최종사용자별
  • 지역별
• 2023년 시장 시나리오

제7장 세계 시장 수요(금액 또는 규모, 백만 달러) 분석

• 과거 시장 매출(백만 달러) 분석, 2019-2023년
• 현재 및 향후 시장 매출(백만 달러) 예측, 2024-2033년
  • 전년대비 성장 동향 분석
  • 절대액 기회 분석

제8장 세계 시장 분석 : 첨가제별

• 서론/주요 조사 결과
• 과거 시장 규모(백만 달러) 분석 : 첨가제별, 2019-2023년
• 현재 및 향후 시장 규모(백만 달러) 분석과 예측 : 첨가제별, 2024년-2033년
  • Natural
  • Artificial
  • Nutritive
  • Non- nutritive
  • Polyols
  • 기타
• 시장의 매력 분석 : 첨가제별

제9장 세계 시장 분석 : 기술별

• 서론/주요 조사 결과
• 과거 시장 규모(백만 달러) 분석 : 기술별, 2019-2023년
• 현재 및 향후 시장 규모(백만 달러) 분석과 예측 : 기술별, 2024-2033년
  • 핫멜트 압출 성형
  • 마이크로 캡슐화
  • 코팅
  • Organoleptic Methods
  • 기타
• 시장의 매력 분석 : 기술별

제10장 세계 시장 분석 : 사용법별

• 서론/주요 조사 결과
• 과거 시장 규모(백만 달러) 분석 : 사용법별, 2019-2023년
• 현재 및 향후 시장 규모(백만 달러) 분석과 예측 : 사용법별, 2024년-2033년
  • 고형 제형
  • 액체 제형
• 시장의 매력 분석 : 사용법별

제11장 세계 시장 분석 : 최종사용자별

• 서론/주요 조사 결과
• 과거 시장 규모(백만 달러) 분석 : 최종사용자별, 2019-2023년
• 현재 및 향후 시장 규모(백만 달러) 분석과 예측 : 최종사용자별, 2024년-2033년
  • 의약품
  • 뉴트라슈티컬
  • 계약 제조 조직
• 시장의 매력 분석 : 최종사용자별

제12장 세계 시장 분석 : 지역별

• 서론
• 과거 시장 규모(백만 달러) 분석 : 지역별, 2019-2023년
• 현재 및 향후 시장 규모(백만 달러) 분석과 예측 : 지역별, 2024년-2033년
  • 북미
  • 라틴아메리카
  • 유럽
  • 남아시아
  • 동아시아
  • 오세아니아
  • 중동 및 아프리카(MEA)
• 시장의 매력 분석 : 지역별

제13장 북미 시장 분석

제14장 라틴아메리카 시장 분석

제15장 유럽 시장 분석

제16장 남아시아 시장 분석

제17장 동아시아 시장 분석

제18장 오세아니아 시장 분석

제19장 중동 및 아프리카 시장 분석

제20장 시장 구조 분석

• 시장 분석 : 기업 Tier별
• 주요 기업의 시장 점유율 분석
• 시장 입지 분석

제21장 경쟁 분석

• 경쟁 대시보드
• 브랜딩 및 프로모션 전략
• 주요 개발 분석
• 경쟁 상세
  • SPI Pharma, Inc.
  • Adare Pharmaceutical Inc.
  • GPT Pharmaceuticals Pvt. Ltd
  • Roquette Freres
  • Rochem International, Inc.
  • Gattefose
  • Asahi Kasei Corporation
  • DuPont de Nemours, Inc
  • Dow Pharma Solutions

제22장 사용된 전제조건과 두자어

제23장 조사 방법

LSH

영문 목차

영문목차

Persistence Market Research has recently released a comprehensive report on the worldwide Pharmaceutical Excipients for Taste Masking Market. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

• Pharmaceutical Excipients for Taste Masking Market Size (2024E): USD 985.6 million
• Projected Market Value (2033F): USD 1,539.2 million
• Global Market Growth Rate (CAGR 2024 to 2033): 5.1%

Pharmaceutical Excipients for Taste Masking Market - Report Scope:

Pharmaceutical excipients for taste masking play a crucial role in the formulation of medications, improving patient compliance by masking unpleasant tastes and odors. These excipients are used across various dosage forms, including tablets, syrups, and powders, to enhance the palatability of pharmaceutical products. The market caters to pharmaceutical manufacturers, contract research organizations (CROs), and contract manufacturing organizations (CMOs), offering a range of excipients including flavoring agents, sweeteners, and coating materials.

Market Growth Drivers:

The global pharmaceutical excipients for taste masking market is propelled by several key factors, including the rising demand for pediatric and geriatric medicines, which require effective taste masking solutions to improve patient adherence. Increased consumer preference for orally administered medications and advancements in excipient technologies, such as the development of new flavor-masking agents and advanced coating materials, further drive market expansion. The growth of the over-the-counter (OTC) pharmaceutical sector and the increasing focus on personalized medicine also contribute to the demand for innovative taste masking solutions.

Market Restraints:

Despite promising growth prospects, the pharmaceutical excipients for taste masking market faces challenges related to the high cost of advanced excipient technologies and regulatory hurdles. Stringent regulations governing the safety and efficacy of excipients impose compliance burdens on manufacturers and increase operational costs. Additionally, the limited availability of taste masking solutions for certain drug formulations and the need for continuous R&D investments to develop novel excipients pose challenges for market penetration.

Market Opportunities:

The pharmaceutical excipients for taste masking market presents significant growth opportunities driven by technological innovations, demographic trends, and evolving pharmaceutical formulations. The integration of advanced technologies, such as nanotechnology and polymer-based excipients, enhances taste masking effectiveness and opens new avenues for market growth. Furthermore, the expanding pharmaceutical industry in emerging markets and the increasing emphasis on patient-centric drug development offer opportunities for market players to introduce cost-effective and efficient taste masking solutions. Strategic partnerships, investments in R&D, and the introduction of user-friendly excipients are essential to capitalize on emerging opportunities and sustain market leadership in the dynamic taste masking landscape.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the pharmaceutical excipients for taste masking market globally?
• Which excipient types and applications are driving taste masking adoption across different pharmaceutical formulations?
• How are technological advancements reshaping the competitive landscape of the pharmaceutical excipients for taste masking market?
• Who are the key players contributing to the pharmaceutical excipients for taste masking market, and what strategies are they employing to maintain market relevance?
• What are the emerging trends and future prospects in the global pharmaceutical excipients for taste masking market?

Competitive Intelligence and Business Strategy:

Leading players in the global pharmaceutical excipients for taste masking market, including Ashland Global Holdings Inc., BASF SE, and DOW Chemical Company, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced taste masking solutions, including novel flavor-masking agents and advanced coating materials, catering to diverse pharmaceutical needs and patient requirements. Collaborations with pharmaceutical manufacturers, research institutions, and regulatory agencies facilitate market access and promote technology adoption. Moreover, emphasis on clinical research, evidence-based practice, and patient education fosters market growth and enhances patient outcomes in the rapidly evolving taste masking landscape.

Key Companies Profiled:

• Ashland Global Holdings Inc.
• BASF SE
• DOW Chemical Company
• Colorcon Inc.
• Ingredion Incorporated
• Roquette Freres
• JRS Pharma
• Lonza Group
• Evonik Industries AG
• Sensient Technologies Corporation

Key Segments Covered in Pharmaceutical Excipients for Taste Masking Industry Research

Excipient:

• Natural
• Artificial
• Nutritive
• Non- nutritive
• Polyols

Technique:

• Hot Melt Extrusion
• Microencapsulation
• Coating
• Organoleptic Methods

Usage:

• Solid Dosage Forms
• Liquid Dosage Forms

End-User:

• Pharmaceuticals
• Nutraceuticals
• Contract Manufacturing Organizations

Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East and Africa

Table of Contents

1. Executive Summary

• 1.1. Global Market Outlook
• 1.2. Demand Side Trends
• 1.3. Supply Side Trends
• 1.4. Analysis and Recommendations

2. Market Overview

• 2.1. Market Coverage / Taxonomy
• 2.2. Market Definition / Scope / Limitations
• 2.3. Inclusions and Exclusions

3. Key Market Trends

• 3.1. Key Trends Impacting the Market
• 3.2. Excipient Innovation / Development Trends

4. Key Success Factors

• 4.1. Product Adoption / Usage Analysis
• 4.2. Product USPs / Features
• 4.3. Recent Product Approval and Launches
• 4.4. Pipeline Assessment
• 4.5. PESTLE Analysis
• 4.6. Porter's Analysis
• 4.7. Regulatory Scenario

5. Market Background

• 5.1. Macro-Economic Factors
  • 5.1.1. Global GDP Growth Outlook
  • 5.1.2. Global Healthcare Expenditure Outlook
  • 5.1.3. Global Excipient Market Outlook
• 5.2. Forecast Factors - Relevance & Impact
  • 5.2.1. Rising Geriatric Population
  • 5.2.2. Technological Advancements
  • 5.2.3. Adoption of Medicine for Paediatric Population
  • 5.2.4. Increasing Chronic Diseases
  • 5.2.5. Increasing Demand of Oral and Patients Compatible Medicines
  • 5.2.6. Growth of The Top Companies
  • 5.2.7. Mergers and Acquisitions
• 5.3. Dynamics
  • 5.3.1. Drivers
  • 5.3.2. Restraints
  • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis - Impact Assessment

• 6.1. COVID-19 and Impact Analysis
  • 6.1.1. By Excipient
  • 6.1.2. By Technique
  • 6.1.3. By Usage
  • 6.1.4. By End User
  • 6.1.5. By Region
• 6.2. 2023 Market Scenario

7. Global Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2033

• 7.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
• 7.2. Current and Future Market Value (US$ Mn) Projections, 2024-2033
  • 7.2.1. Y-o-Y Growth Trend Analysis
  • 7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Excipient

• 8.1. Introduction / Key Findings
• 8.2. Historical Market Size (US$ Mn) Analysis By Excipient, 2019-2023
• 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Excipient, 2024-2033
  • 8.3.1. Natural
  • 8.3.2. Artificial
  • 8.3.3. Nutritive
  • 8.3.4. Non- nutritive
  • 8.3.5. Polyols
  • 8.3.6. Others
• 8.4. Market Attractiveness Analysis By Excipient

9. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Technique

• 9.1. Introduction / Key Findings
• 9.2. Historical Market Size (US$ Mn) Analysis By Technique, 2019-2023
• 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Technique, 2024-2033
  • 9.3.1. Hot Melt Extrusion
  • 9.3.2. Microencapsulation
  • 9.3.3. Coating
  • 9.3.4. Organoleptic Methods
  • 9.3.5. Others
• 9.4. Market Attractiveness Analysis By Technique

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Usage

• 10.1. Introduction / Key Findings
• 10.2. Historical Market Size (US$ Mn) Analysis By Usage, 2019-2023
• 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Usage, 2024-2033
  • 10.3.1. Solid Dosage Forms
    • 10.3.1.1. Tablets
    • 10.3.1.2. Granules
    • 10.3.1.3. Capsules
  • 10.3.2. Liquid Dosage Forms
• 10.4. Market Attractiveness Analysis By Usage

11. Global Market Analysis 2019-2023 and Forecast 2024-2033, by End User

• 11.1. Introduction / Key Findings
• 11.2. Historical Market Size (US$ Mn) Analysis By End User, 2019-2023
• 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2024-2033
  • 11.3.1. Pharmaceuticals
  • 11.3.2. Nutraceuticals
  • 11.3.3. Contract Manufacturing Organizations
• 11.4. Market Attractiveness Analysis By End User

12. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Region

• 12.1. Introduction
• 12.2. Historical Market Size (US$ Mn) Analysis By Region, 2019-2023
• 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2024-2033
  • 12.3.1. North America
  • 12.3.2. Latin America
  • 12.3.3. Europe
  • 12.3.4. South Asia
  • 12.3.5. East Asia
  • 12.3.6. Oceania
  • 12.3.7. Middle East and Africa (MEA)
• 12.4. Market Attractiveness Analysis By Region

13. North America Market Analysis 2019-2023 and Forecast 2024-2033

• 13.1. Introduction
• 13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2023
• 13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2033
  • 13.3.1. By Country
    • 13.3.1.1. U.S.
    • 13.3.1.2. Canada
  • 13.3.2. By Excipient
  • 13.3.3. By Technique
  • 13.3.4. By Usage
  • 13.3.5. By End User
• 13.4. Market Attractiveness Analysis
  • 13.4.1. By Country
  • 13.4.2. By Excipient
  • 13.4.3. By Technique
  • 13.4.4. By Usage
  • 13.4.5. By End User
• 13.5. Country Level Analysis & Forecast
  • 13.5.1. U.S. Market Analysis
    • 13.5.1.1. Introduction
    • 13.5.1.2. Market Analysis and Forecast by Market Taxonomy
      • 13.5.1.2.1. By Excipient
      • 13.5.1.2.2. By Technique
      • 13.5.1.2.3. By Usage
      • 13.5.1.2.4. By End User
  • 13.5.2. Canada Market Analysis
    • 13.5.2.1. Introduction
    • 13.5.2.2. Market Analysis and Forecast by Market Taxonomy
      • 13.5.2.2.1. By Excipient
      • 13.5.2.2.2. By Technique
      • 13.5.2.2.3. By Usage
      • 13.5.2.2.4. By End User
• 13.6. Market Trends
• 13.7. Key Market Participants - Intensity Mapping
• 13.8. Drivers and Restraints - Impact Analysis

14. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

• 14.1. Introduction
• 14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2023
• 14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2033
  • 14.3.1. By Country
    • 14.3.1.1. Brazil
    • 14.3.1.2. Mexico
    • 14.3.1.3. Argentina
    • 14.3.1.4. Rest of Latin America
  • 14.3.2. By Technique
  • 14.3.3. By Usage
  • 14.3.4. By End User
• 14.4. Market Attractiveness Analysis
  • 14.4.1. By Country
  • 14.4.2. By Excipient
  • 14.4.3. By Technique
  • 14.4.4. By Usage
  • 14.4.5. By End User
• 14.5. Country Level Analysis & Forecast
  • 14.5.1. Brazil Market Analysis
    • 14.5.1.1. Introduction
    • 14.5.1.2. Market Analysis and Forecast by Market Taxonomy
      • 14.5.1.2.1. By Excipient
      • 14.5.1.2.2. By Technique
      • 14.5.1.2.3. By Usage
      • 14.5.1.2.4. By End User
  • 14.5.2. Mexico Market Analysis
    • 14.5.2.1. Introduction
    • 14.5.2.2. Market Analysis and Forecast by Market Taxonomy
      • 14.5.2.2.1. By Excipient
      • 14.5.2.2.2. By Technique
      • 14.5.2.2.3. By Usage
      • 14.5.2.2.4. By End User
  • 14.5.3. Argentina Market Analysis
    • 14.5.3.1. Introduction
    • 14.5.3.2. Market Analysis and Forecast by Market Taxonomy
      • 14.5.3.2.1. By Excipient
      • 14.5.3.2.2. By Technique
      • 14.5.3.2.3. By Usage
      • 14.5.3.2.4. By End User
• 14.6. Market Trends
• 14.7. Key Market Participants - Intensity Mapping
• 14.8. Drivers and Restraints - Impact Analysis

15. Europe Market Analysis 2019-2023 and Forecast 2024-2033

• 15.1. Introduction
• 15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2023
• 15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2033
  • 15.3.1. By Country
    • 15.3.1.1. Germany
    • 15.3.1.2. France
    • 15.3.1.3. Italy
    • 15.3.1.4. U.K.
    • 15.3.1.5. Spain
    • 15.3.1.6. Russia
    • 15.3.1.7. BENELUX
    • 15.3.1.8. Nordic Countries
    • 15.3.1.9. Rest of Europe
  • 15.3.2. By Excipient
  • 15.3.3. By Technique
  • 15.3.4. By Usage
  • 15.3.5. By End User
• 15.4. Market Attractiveness Analysis
  • 15.4.1. By Country
  • 15.4.2. By Excipient
  • 15.4.3. By Technique
  • 15.4.4. By Usage
  • 15.4.5. By End User
• 15.5. Country Level Analysis & Forecast
  • 15.5.1. Germany Market Analysis
    • 15.5.1.1. Introduction
    • 15.5.1.2. Market Analysis and Forecast by Market Taxonomy
      • 15.5.1.2.1. By Excipient
      • 15.5.1.2.2. By Technique
      • 15.5.1.2.3. By Usage
      • 15.5.1.2.4. By End User
  • 15.5.2. France Market Analysis
    • 15.5.2.1. Introduction
    • 15.5.2.2. Market Analysis and Forecast by Market Taxonomy
      • 15.5.2.2.1. By Excipient
      • 15.5.2.2.2. By Technique
      • 15.5.2.2.3. By Usage
      • 15.5.2.2.4. By End User
  • 15.5.3. Italy Market Analysis
    • 15.5.3.1. Introduction
    • 15.5.3.2. Market Analysis and Forecast by Market Taxonomy
      • 15.5.3.2.1. By Excipient
      • 15.5.3.2.2. By Technique
      • 15.5.3.2.3. By Usage
      • 15.5.3.2.4. By End User
  • 15.5.4. U.K. Market Analysis
    • 15.5.4.1. Introduction
    • 15.5.4.2. Market Analysis and Forecast by Market Taxonomy
      • 15.5.4.2.1. By Excipient
      • 15.5.4.2.2. By Technique
      • 15.5.4.2.3. By Usage
      • 15.5.4.2.4. By End User
  • 15.5.5. Spain Market Analysis
    • 15.5.5.1. Introduction
    • 15.5.5.2. Market Analysis and Forecast by Market Taxonomy
      • 15.5.5.2.1. By Excipient
      • 15.5.5.2.2. By Technique
      • 15.5.5.2.3. By Usage
      • 15.5.5.2.4. By End User
  • 15.5.6. Russia Market Analysis
    • 15.5.6.1. Introduction
    • 15.5.6.2. Market Analysis and Forecast by Market Taxonomy
      • 15.5.6.2.1. By Excipient
      • 15.5.6.2.2. By Technique
      • 15.5.6.2.3. By Usage
      • 15.5.6.2.4. By End User
  • 15.5.7. Nordic Countries Market Analysis
    • 15.5.7.1. Introduction
    • 15.5.7.2. Market Analysis and Forecast by Market Taxonomy
      • 15.5.7.2.1. By Excipient
      • 15.5.7.2.2. By Technique
      • 15.5.7.2.3. By Usage
      • 15.5.7.2.4. By End User
  • 15.5.8. BENELUX Market Analysis
    • 15.5.8.1. Introduction
    • 15.5.8.2. Market Analysis and Forecast by Market Taxonomy
      • 15.5.8.2.1. By Excipient
      • 15.5.8.2.2. By Technique
      • 15.5.8.2.3. By Usage
      • 15.5.8.2.4. By End User
• 15.6. Market Trends
• 15.7. Key Market Participants - Intensity Mapping
• 15.8. Drivers and Restraints - Impact Analysis

16. South Asia Market Analysis 2019-2023 and Forecast 2024-2033

• 16.1. Introduction
• 16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2023
• 16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2033
  • 16.3.1. By Country
    • 16.3.1.1. India
    • 16.3.1.2. Thailand
    • 16.3.1.3. Indonesia
    • 16.3.1.4. Malaysia
    • 16.3.1.5. Rest of South Asia
  • 16.3.2. By Excipient
  • 16.3.3. By Technique
  • 16.3.4. By Usage
  • 16.3.5. By End User
• 16.4. Market Attractiveness Analysis
  • 16.4.1. By Country
  • 16.4.2. By Excipient
  • 16.4.3. By Technique
  • 16.4.4. By Usage
  • 16.4.5. By End User
• 16.5. Country Level Analysis & Forecast
  • 16.5.1. India Market Analysis
    • 16.5.1.1. Introduction
    • 16.5.1.2. Market Analysis and Forecast by Market Taxonomy
      • 16.5.1.2.1. By Excipient
      • 16.5.1.2.2. By Technique
      • 16.5.1.2.3. By Usage
      • 16.5.1.2.4. By End User
  • 16.5.2. Thailand Market Analysis
    • 16.5.2.1. Introduction
    • 16.5.2.2. Market Analysis and Forecast by Market Taxonomy
      • 16.5.2.2.1. By Excipient
      • 16.5.2.2.2. By Technique
      • 16.5.2.2.3. By Usage
      • 16.5.2.2.4. By End User
  • 16.5.3. Indonesia Market Analysis
    • 16.5.3.1. Introduction
    • 16.5.3.2. Market Analysis and Forecast by Market Taxonomy
      • 16.5.3.2.1. By Excipient
      • 16.5.3.2.2. By Technique
      • 16.5.3.2.3. By Usage
      • 16.5.3.2.4. By End User
  • 16.5.4. Malaysia Market Analysis
    • 16.5.4.1. Introduction
    • 16.5.4.2. Market Analysis and Forecast by Market Taxonomy
      • 16.5.4.2.1. By Excipient
      • 16.5.4.2.2. By Technique
      • 16.5.4.2.3. By Usage
      • 16.5.4.2.4. By End User
• 16.6. Market Trends
• 16.7. Key Market Participants - Intensity Mapping
• 16.8. Drivers and Restraints - Impact Analysis

17. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

• 17.1. Introduction
• 17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2023
• 17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2033
  • 17.3.1. By Country
    • 17.3.1.1. China
    • 17.3.1.2. Japan
    • 17.3.1.3. South Korea
  • 17.3.2. By Excipient
  • 17.3.3. By Technique
  • 17.3.4. By Usage
  • 17.3.5. By End User
• 17.4. Market Attractiveness Analysis
  • 17.4.1. By Country
  • 17.4.2. By Excipient
  • 17.4.3. By Technique
  • 17.4.4. By Usage
  • 17.4.5. By End User
• 17.5. Country Level Analysis & Forecast
  • 17.5.1. China Market Analysis
    • 17.5.1.1. Introduction
    • 17.5.1.2. Market Analysis and Forecast by Market Taxonomy
      • 17.5.1.2.1. By Excipient
      • 17.5.1.2.2. By Technique
      • 17.5.1.2.3. By Usage
      • 17.5.1.2.4. By End User
  • 17.5.2. Japan Market Analysis
    • 17.5.2.1. Introduction
    • 17.5.2.2. Market Analysis and Forecast by Market Taxonomy
      • 17.5.2.2.1. By Excipient
      • 17.5.2.2.2. By Technique
      • 17.5.2.2.3. By Usage
      • 17.5.2.2.4. By End User
  • 17.5.3. South Korea Market Analysis
    • 17.5.3.1. Introduction
    • 17.5.3.2. Market Analysis and Forecast by Market Taxonomy
      • 17.5.3.2.1. By Excipient
      • 17.5.3.2.2. By Technique
      • 17.5.3.2.3. By Usage
      • 17.5.3.2.4. By End User
• 17.6. Market Trends
• 17.7. Key Market Participants - Intensity Mapping
• 17.8. Drivers and Restraints - Impact Analysis

18. Oceania Market Analysis 2019-2023 and Forecast 2024-2033

• 18.1. Introduction
• 18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2023
• 18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2033
  • 18.3.1. By Country
    • 18.3.1.1. Australia
    • 18.3.1.2. New Zealand
  • 18.3.2. By Excipient
  • 18.3.3. By Technique
  • 18.3.4. By Usage
  • 18.3.5. By End User
• 18.4. Market Attractiveness Analysis
  • 18.4.1. By Country
  • 18.4.2. By Excipient
  • 18.4.3. By Technique
  • 18.4.4. By Usage
  • 18.4.5. By End User
• 18.5. Country Level Analysis & Forecast
  • 18.5.1. Australia Market Analysis
    • 18.5.1.1. Introduction
    • 18.5.1.2. Market Analysis and Forecast by Market Taxonomy
      • 18.5.1.2.1. By Excipient
      • 18.5.1.2.2. By Technique
      • 18.5.1.2.3. By Usage
      • 18.5.1.2.4. By End User
  • 18.5.2. New Zealand Market Analysis
    • 18.5.2.1. Introduction
    • 18.5.2.2. Market Analysis and Forecast by Market Taxonomy
      • 18.5.2.2.1. By Excipient
      • 18.5.2.2.2. By Technique
      • 18.5.2.2.3. By Usage
      • 18.5.2.2.4. By End User
• 18.6. Market Trends
• 18.7. Key Market Participants - Intensity Mapping
• 18.8. Drivers and Restraints - Impact Analysis

19. Middle East and Africa Market Analysis 2019-2023 and Forecast 2024-2033

• 19.1. Introduction
• 19.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2023
• 19.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2033
  • 19.3.1. By Country
    • 19.3.1.1. GCC Countries
    • 19.3.1.2. Turkiye
    • 19.3.1.3. Northern Africa
    • 19.3.1.4. South Africa
    • 19.3.1.5. Rest of Middle East and Africa
  • 19.3.2. By Excipient
  • 19.3.3. By Technique
  • 19.3.4. By Usage
  • 19.3.5. By End User
• 19.4. Market Attractiveness Analysis
  • 19.4.1. By Country
  • 19.4.2. By Excipient
  • 19.4.3. By Technique
  • 19.4.4. By Usage
  • 19.4.5. By End User
• 19.5. Country Level Analysis & Forecast
  • 19.5.1. GCC Countries Market Analysis
    • 19.5.1.1. Introduction
    • 19.5.1.2. Market Analysis and Forecast by Market Taxonomy
      • 19.5.1.2.1. By Excipient
      • 19.5.1.2.2. By Technique
      • 19.5.1.2.3. By Usage
      • 19.5.1.2.4. By End User
  • 19.5.2. Turkiye Market Analysis
    • 19.5.2.1. Introduction
    • 19.5.2.2. Market Analysis and Forecast by Market Taxonomy
      • 19.5.2.2.1. By Excipient
      • 19.5.2.2.2. By Technique
      • 19.5.2.2.3. By Usage
      • 19.5.2.2.4. By End User
  • 19.5.3. Northern Africa Market Analysis
    • 19.5.3.1. Introduction
    • 19.5.3.2. Market Analysis and Forecast by Market Taxonomy
      • 19.5.3.2.1. By Excipient
      • 19.5.3.2.2. By Technique
      • 19.5.3.2.3. By Usage
      • 19.5.3.2.4. By End User
  • 19.5.4. South Africa Market Analysis
    • 19.5.4.1. Introduction
    • 19.5.4.2. Market Analysis and Forecast by Market Taxonomy
      • 19.5.4.2.1. By Excipient
      • 19.5.4.2.2. By Technique
      • 19.5.4.2.3. By Usage
      • 19.5.4.2.4. By End User
• 19.6. Market Trends
• 19.7. Key Market Participants - Intensity Mapping
• 19.8. Drivers and Restraints - Impact Analysis

20. Market Structure Analysis

• 20.1. Market Analysis by Tier of Companies
• 20.2. Market Share Analysis of Top Players
• 20.3. Market Presence Analysis

21. Competition Analysis

• 21.1. Competition Dashboard
• 21.2. Branding and Promotional Strategies
• 21.3. Key Development Analysis
• 21.4. Competition Deep Dive
  • 21.4.1. SPI Pharma, Inc.
    • 21.4.1.1. Overview
    • 21.4.1.2. Excipient Portfolio
    • 21.4.1.3. Key financials
    • 21.4.1.4. Sales Footprint
    • 21.4.1.5. Strategy Overview
      • 21.4.1.5.1. Marketing Strategy
      • 21.4.1.5.2. Product Strategy
      • 21.4.1.5.3. Channel Strategy
  • 21.4.2. Adare Pharmaceutical Inc.
    • 21.4.2.1. Overview
    • 21.4.2.2. Excipient Portfolio
    • 21.4.2.3. Key financials
    • 21.4.2.4. Sales Footprint
    • 21.4.2.5. Strategy Overview
      • 21.4.2.5.1. Marketing Strategy
      • 21.4.2.5.2. Product Strategy
      • 21.4.2.5.3. Channel Strategy
  • 21.4.3. GPT Pharmaceuticals Pvt. Ltd
    • 21.4.3.1. Overview
    • 21.4.3.2. Excipient Portfolio
    • 21.4.3.3. Key financials
    • 21.4.3.4. Sales Footprint
    • 21.4.3.5. Strategy Overview
      • 21.4.3.5.1. Marketing Strategy
      • 21.4.3.5.2. Product Strategy
      • 21.4.3.5.3. Channel Strategy
  • 21.4.4. Roquette Freres
    • 21.4.4.1. Overview
    • 21.4.4.2. Excipient Portfolio
    • 21.4.4.3. Key financials
    • 21.4.4.4. Sales Footprint
    • 21.4.4.5. Strategy Overview
      • 21.4.4.5.1. Marketing Strategy
      • 21.4.4.5.2. Product Strategy
      • 21.4.4.5.3. Channel Strategy
  • 21.4.5. Rochem International, Inc.
    • 21.4.5.1. Overview
    • 21.4.5.2. Excipient Portfolio
    • 21.4.5.3. Key financials
    • 21.4.5.4. Sales Footprint
    • 21.4.5.5. Strategy Overview
      • 21.4.5.5.1. Marketing Strategy
      • 21.4.5.5.2. Product Strategy
      • 21.4.5.5.3. Channel Strategy
  • 21.4.6. Gattefose
    • 21.4.6.1. Overview
    • 21.4.6.2. Excipient Portfolio
    • 21.4.6.3. Key financials
    • 21.4.6.4. Sales Footprint
    • 21.4.6.5. Strategy Overview
      • 21.4.6.5.1. Marketing Strategy
      • 21.4.6.5.2. Product Strategy
      • 21.4.6.5.3. Channel Strategy
  • 21.4.7. Asahi Kasei Corporation
    • 21.4.7.1. Overview
    • 21.4.7.2. Excipient Portfolio
    • 21.4.7.3. Key financials
    • 21.4.7.4. Sales Footprint
    • 21.4.7.5. Strategy Overview
      • 21.4.7.5.1. Marketing Strategy
      • 21.4.7.5.2. Product Strategy
      • 21.4.7.5.3. Channel Strategy
  • 21.4.8. DuPont de Nemours, Inc
    • 21.4.8.1. Overview
    • 21.4.8.2. Excipient Portfolio
    • 21.4.8.3. Key financials
    • 21.4.8.4. Sales Footprint
    • 21.4.8.5. Strategy Overview
      • 21.4.8.5.1. Marketing Strategy
      • 21.4.8.5.2. Product Strategy
      • 21.4.8.5.3. Channel Strategy
  • 21.4.9. Dow Pharma Solutions
    • 21.4.9.1. Overview
    • 21.4.9.2. Excipient Portfolio
    • 21.4.9.3. Key financials
    • 21.4.9.4. Sales Footprint
    • 21.4.9.5. Strategy Overview
      • 21.4.9.5.1. Marketing Strategy
      • 21.4.9.5.2. Product Strategy
      • 21.4.9.5.3. Channel Strategy

22. Assumptions and Acronyms Used

23. Research Methodology

관련자료